ACM
CLB icon

Ashford Capital Management’s Core Laboratories CLB Stock Holding History

Ashford Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-7,000
Closed -$418K – 99
2018
Q4 		$418K Sell
7,000
-28,850
-80% -$2.49M 0.07% 94
2018
Q3 		$4.15M Sell
35,850
-1,563
-4% -$176K 0.5% 44
2018
Q2 		$4.72M Sell
37,413
-410
-1% -$49.9K 0.62% 38
2018
Q1 		$4.09M Buy
37,823
+873
+2% +$96.6K 0.62% 39
2017
Q4 		$4.05M Buy
36,950
+18,800
+104% +$1.88M 0.63% 37
2017
Q3 		$1.79M Sell
18,150
-474
-3% -$45.9K 0.29% 55
2017
Q2 		$1.89M Buy
18,624
+700
+4% +$75.5K 0.33% 51
2017
Q1 		$2.07M Buy
17,924
+1,097
+7% +$127K 0.4% 51
2016
Q4 		$2.02M Buy
16,827
+124
+0.7% +$13.7K 0.41% 50
2016
Q3 		$1.88M Buy
16,703
+140
+0.8% +$16.1K 0.39% 57
2016
Q2 		$2.05M Buy
16,563
+26
+0.2% +$3.14K 0.46% 53
2016
Q1 		$1.86M Buy
16,537
+137
+0.8% +$14.2K 0.44% 52
2015
Q4 		$1.78M Hold
16,400
– – 0.42% 53
2015
Q3 		$1.64M Buy
16,400
+50
+0.3% +$5.44K 0.38% 61
2015
Q2 		$1.86M Hold
16,350
– – 0.41% 61
2015
Q1 		$1.71M Sell
16,350
-8,425
-34% -$898K 0.35% 71
2014
Q4 		$2.98M Sell
24,775
-8,540
-26% -$1.12M 0.59% 60
2014
Q3 		$4.88M Sell
33,315
-500
-1% -$77.2K 1.05% 42
2014
Q2 		$5.65M Buy
33,815
+3,875
+13% +$689K 1.13% 30
2014
Q1 		$5.94M Sell
29,940
-1,650
-5% -$311K 1.15% 33
2013
Q4 		$6.03M Sell
31,590
-4,600
-13% -$856K 1.15% 33
2013
Q3 		$6.12M Sell
36,190
-2,750
-7% -$427K 1.22% 34
2013
Q2 		$5.91M Buy
+38,940
New +$5.52M 1.28% 34

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Ashford Capital Management's CLB Position: Q1 2019 in Review

Ashford Capital Management sold out of Core Laboratories (CLB) in Q1 2019, closing a stake of 7,000 shares — an estimated $418K sold.

Ashford Capital Management first reported a position in CLB in Q2 2013 and held it in 23 quarters. The position peaked at $6.12M in Q3 2013. 313 funds tracked by Wall St. Rank hold CLB as of Q1 2019.

  • Ashford Capital Management reported no remaining Core Laboratories position as of Q1 2019 after selling out during the quarter.
  • Ashford Capital Management sold 7,000 Core Laboratories shares in Q1 2019, an estimated $418K.
  • Ashford Capital Management first reported a position in Core Laboratories in Q2 2013 and held it in 23 quarters.
  • Ashford Capital Management's Core Laboratories position peaked at $6.12M in Q3 2013.
  • 313 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2019.

Based on Ashford Capital Management's 13F filing for Q1 2019, filed 15 May 2019.